Clinical Trial Update: Study to Assess S303 RBCs and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute Anemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of S303 RBCs in patients requiring transfusion for acute anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• S303 RBCs

Snippet

Sponsor: Cerus Corporation | Conditions: Focus:Use of S303 RBCs in Patients With Acute Anemia | Phase 3 | Status: COMPLETED